Literature DB >> 12906911

Simple and sensitive high-performance liquid chromatography method for simultaneous determination of urinary free cortisol and 6beta-hydroxycortisol in routine practice. For CYP 3A4 activity evaluation in basal conditions and after grapefruit juice intake.

E Rouits1, M Boisdron-Celle, A Morel, E Gamelin.   

Abstract

Cytochrome p450 3A4 activity displays a wide variability. The urinary 6beta-hydroxycortisol to cortisol ratio, as a non-invasive assay, can be useful for its pretherapeutic characterization. We developed an HPLC-UV method preceded by liquid-liquid extraction for assessment of this ratio in clinical practice. Urine was collected on second void morning-spot sample. Percentage recoveries were high and reproducible. The 6beta-hydroxycortisol to cortisol ratio ranged from 1.6 to 9.9 in 12 Caucasian healthy volunteers. It was reduced by 30 to 70% after ingestion of white grapefruit juice, a CYP3A4 inhibitor. Our method, simple, sensitive and accurate, could be helpful for determination of CYP 3A4 activity before oral chemotherapy, or for the monitoring of the use of grapefruit juice as a pharmacological modulator.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12906911     DOI: 10.1016/s1570-0232(03)00353-2

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients.

Authors:  An Wang; Bang-Ning Yu; Chen-Hui Luo; Zhi-Rong Tan; Gan Zhou; Lian-Sheng Wang; Wei Zhang; Zhi Li; Jie Liu; Hong-Hao Zhou
Journal:  Eur J Clin Pharmacol       Date:  2005-01-14       Impact factor: 2.953

2.  Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients.

Authors:  E Rouits; V Charasson; A Pétain; M Boisdron-Celle; J-P Delord; M Fonck; A Laurand; A-L Poirier; A Morel; E Chatelut; J Robert; E Gamelin
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.